These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2538557)

  • 1. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 77(1):65-71. PubMed ID: 2545813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
    Okuyama S; Imagawa Y; Tomisawa K
    Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
    Svensson A; Carlsson A; Carlsson ML
    J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
    Maj J; Skuza G; Rogóz Z
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):53-62. PubMed ID: 8105798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801-induced stereotypy and its antagonism by neuroleptic drugs.
    Tiedtke PI; Bischoff C; Schmidt WJ
    J Neural Transm Gen Sect; 1990; 81(3):173-82. PubMed ID: 1975747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of blockade by MK-801 of N-methyl-D-aspartate-induced increase in intracellular Ca2+ in cultured mouse hippocampal neurons.
    Yuzaki M; Miyawaki A; Akita K; Kudo Y; Ogura A; Ino H; Mikoshiba K
    Brain Res; 1990 May; 517(1-2):51-6. PubMed ID: 2165437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
    Carlsson M; Svensson A
    Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
    Butelman ER
    Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological characterization.
    Balázs R; Hack N; Jørgensen OS; Cotman CW
    Neurosci Lett; 1989 Jul; 101(3):241-6. PubMed ID: 2549463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
    Kim HS; Rhee GS; Oh S; Park WK
    Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The topography of MK-801-induced locomotor patterns in rats.
    Ford LM; Norman AB; Sanberg PR
    Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.